Mehmet Enes Coşkun
Research Subjects
Mehmet Enes Coşkun has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Ali Bay
Department of Pediatrics, Division of Pediatric Hematology, Gaziantep University, Gaziantep, Turkey
4 shared publications - Hatice Uygun
Department of Pediatric Infectious Disease, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey
4 shared publications - Sercan Ergun
Department of Medical Biology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
4 shared publications Elif Aktekin
3 shared publicationsFatih Yilmaz
T Department of Pediatrics , Gaziantep University Faculty of Medicine , Gaziantep , Turkey
3 shared publications- Munevver Tugba Temel
Pediatric Cardiology, Gaziantep University Medical Faculty, Gaziantep, Turkey
3 shared publications
Latest Publications
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (2) , 82-87
Does Blood Type Have an Effect on Response to Hepatitis B Vaccine in Children? Single Center Data
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (2) , 82-87
Does Blood Type Have an Effect on Response to Hepatitis B Vaccine in Children? Single Center Data
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (2) , 80-85
Kan Grubunun Çocuklarda Hepatit B Aşısına Yanıt Üzerinde Etkisi Var mı? Tek Merkez Verileri
- 25 June 2024
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 18 (2) , 80-85
Kan Grubunun Çocuklarda Hepatit B Aşısına Yanıt Üzerinde Etkisi Var mı? Tek Merkez Verileri
- 23 September 2022
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 16 (3) , 158-162
Association of Brucella Infection with ABO Blood Groups in Children
- 23 September 2022
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 16 (3) , 158-162
Association of Brucella Infection with ABO Blood Groups in Children
- 1 September 2022
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 16 (3) , 156-160
Association of Brucella Infection with ABO Blood Groups in Children
- 1 September 2022
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 16 (3) , 156-160
Association of Brucella Infection with ABO Blood Groups in Children
- Open Access
- 1 December 2020
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 26 (4) , 303-306
Comparison of CRP, Full Blood Count Parameters and Transaminases across Different Age Groups of Children with Mycoplasma Pneumonia
Mycoplasma pneumonia,CRP,children,full blood count
- 1 December 2020
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 26 (4) , 303-306
Open AccessComparison of CRP, Full Blood Count Parameters and Transaminases across Different Age Groups of Children with Mycoplasma Pneumonia
Mycoplasma pneumonia,CRP,children,full blood count
- 5 September 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (10) , 1015-1019
Score‐based diagnostic approach to celiac disease and bone mineral density
Background: The aim of this study was to assess the performance of a score‐based diagnostic approach (SBDA) proposed in the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2012 guideline, and the usefulness of bone mineral density (BMD) measurement in SBDA as an objective finding in the diagnosis of celiac disease (CD).Methods: The SBDA scores of 153 biopsy‐proven celiac diagnosed children (derived from symptomatology, serology, human leukocyte antigen [HLA] analysis, histology) were calculated. Additionally, BMD Z scores obtained at diagnosis were also investigated. The diagnostic sensitivity of SBDA was tested in different scenarios in which low BMD was scored as a diagnostic finding.Results: The mean age of children was 9.48 ± 3.59 years and 54.2% were female. All patients scored ≥4, which is the minimum score to diagnose CD in SBDA. Mean BMD Z score in 142 of 153 patients was −2.70 ± 1.16, and 73.9% of them were below −2. Moreover, different diagnostic scenarios without histology were tested. In one of them, BMD and HLA were not included and the sensitivity was 85.2%. In another one, low BMD was scored as an equivalent of malabsorption, HLA was not included and sensitivity was 97.2%. The sensitivities of these scenarios were significantly different (P = 0.001).Conclusion: In the absence of both HLA and histology, accepting low BMD as an equivalent of malabsorption drastically increased the diagnostic sensitivity, while SBDA had limited success. Therefore, BMD might be useful when HLA and biopsy are not available.
- 5 September 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (10) , 1015-1019
Score‐based diagnostic approach to celiac disease and bone mineral density
Background: The aim of this study was to assess the performance of a score‐based diagnostic approach (SBDA) proposed in the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2012 guideline, and the usefulness of bone mineral density (BMD) measurement in SBDA as an objective finding in the diagnosis of celiac disease (CD).Methods: The SBDA scores of 153 biopsy‐proven celiac diagnosed children (derived from symptomatology, serology, human leukocyte antigen [HLA] analysis, histology) were calculated. Additionally, BMD Z scores obtained at diagnosis were also investigated. The diagnostic sensitivity of SBDA was tested in different scenarios in which low BMD was scored as a diagnostic finding.Results: The mean age of children was 9.48 ± 3.59 years and 54.2% were female. All patients scored ≥4, which is the minimum score to diagnose CD in SBDA. Mean BMD Z score in 142 of 153 patients was −2.70 ± 1.16, and 73.9% of them were below −2. Moreover, different diagnostic scenarios without histology were tested. In one of them, BMD and HLA were not included and the sensitivity was 85.2%. In another one, low BMD was scored as an equivalent of malabsorption, HLA was not included and sensitivity was 97.2%. The sensitivities of these scenarios were significantly different (P = 0.001).Conclusion: In the absence of both HLA and histology, accepting low BMD as an equivalent of malabsorption drastically increased the diagnostic sensitivity, while SBDA had limited success. Therefore, BMD might be useful when HLA and biopsy are not available.
- 1 January 2019
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 22 (5) , 727-730
Plateletcrit: A possible biomarker of inflammation in hepatitis A infection
Te the changes in PCT percentages during HepA infection. Subjects and Methods: Seventy-three children with a diagnosis of acute HepA infection and 68 age- and sex-matched healthy controls were enrolled in this study. Their values of platelet indices [PCT and mean platelet volume (MPV)] obtained from complete blood counts, which were analyzed by XN-1000 analyzer, were statistically compared with each other. Results: PCT and MPV of the patients were found to be higher than those of controls (8.89 ± 1.30 vs 8.03 ± 0.89 for MPV and 0.29 ± 0.11 vs 0.24 ± 0.05 for PCT; P = 0.000, P = 0.002, respectively). In addition, PCT and platelet counts showed a significant negative correlation with alanine aminotransferase (ALT) levels, which indirectly represents inflammation in the liver (PCT: r = −0.368, P = 0.002; platelet count: r = −0.304, P = 0.009). In contrast, MPV levels were not found to demonstrate any correlation with ALT (r = −0.205, P = 0.082). Conclusion: Both MPV and PCT are capable of reflecting the inflammation during acute HepA inflammation. Also, PCT shows a significant negative correlation with the degree of inflammation....
- 1 January 2019
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 22 (5) , 727-730
Plateletcrit: A possible biomarker of inflammation in hepatitis A infection
Te the changes in PCT percentages during HepA infection. Subjects and Methods: Seventy-three children with a diagnosis of acute HepA infection and 68 age- and sex-matched healthy controls were enrolled in this study. Their values of platelet indices [PCT and mean platelet volume (MPV)] obtained from complete blood counts, which were analyzed by XN-1000 analyzer, were statistically compared with each other. Results: PCT and MPV of the patients were found to be higher than those of controls (8.89 ± 1.30 vs 8.03 ± 0.89 for MPV and 0.29 ± 0.11 vs 0.24 ± 0.05 for PCT; P = 0.000, P = 0.002, respectively). In addition, PCT and platelet counts showed a significant negative correlation with alanine aminotransferase (ALT) levels, which indirectly represents inflammation in the liver (PCT: r = −0.368, P = 0.002; platelet count: r = −0.304, P = 0.009). In contrast, MPV levels were not found to demonstrate any correlation with ALT (r = −0.205, P = 0.082). Conclusion: Both MPV and PCT are capable of reflecting the inflammation during acute HepA inflammation. Also, PCT shows a significant negative correlation with the degree of inflammation....
- 14 July 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome
Budd-Chiari syndrome (BCS) is caused by hepatic venous outflow obstruction commonly seen with myeloproliferative neoplasms (MPNs). Polycythaemia vera (PV) is a very rare MPN in childhood. This is the youngest reported patient diagnosed with PV and BCS secondary toJAK V617Fmutation.A 26-month-old girl was admitted with a 5-month history of abdominal distension, hepatosplenomegaly and ascites. Imaging studies revealed occlusion of the right hepatic vein and marked attenuation of the middle and left hepatic veins. BCS was diagnosed after excluding other causes of chronic liver disease. Mandatory prothrombotic workup revealed underlying PV.Partial recanalisation of hepatic veins occurred following anticoagulation therapy and PV was well controlled by pegylated interferon and hydroxycarbamide until she developed nephrotic syndrome, likely secondary to pegylated interferon. Therefore, treatment was modified to ruxolitinib, a novel-JAK-2 inhibitor; the therapy has been effective for almost 20 months with a good response and has no side effects.
- 14 July 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome
Budd-Chiari syndrome (BCS) is caused by hepatic venous outflow obstruction commonly seen with myeloproliferative neoplasms (MPNs). Polycythaemia vera (PV) is a very rare MPN in childhood. This is the youngest reported patient diagnosed with PV and BCS secondary toJAK V617Fmutation.A 26-month-old girl was admitted with a 5-month history of abdominal distension, hepatosplenomegaly and ascites. Imaging studies revealed occlusion of the right hepatic vein and marked attenuation of the middle and left hepatic veins. BCS was diagnosed after excluding other causes of chronic liver disease. Mandatory prothrombotic workup revealed underlying PV.Partial recanalisation of hepatic veins occurred following anticoagulation therapy and PV was well controlled by pegylated interferon and hydroxycarbamide until she developed nephrotic syndrome, likely secondary to pegylated interferon. Therefore, treatment was modified to ruxolitinib, a novel-JAK-2 inhibitor; the therapy has been effective for almost 20 months with a good response and has no side effects.
- Open Access
- 1 January 2017
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 45 (6) , 5-532
Prevalence and characteristics of coronary artery anomalies in children with congenital heart disease diagnosed with coronary angiography
Aim of the present study was to determine the prevalence of coronary artery anomalies in children with congenital heart disease. Data of 1138 consecutive patients who were referred for cardiac catheterization and angiography for assessment of coronary anomaly between January 2005 and December 2009 were retrospectively analyzed. Total of 515 patients whose coronary arteries could be examined through left ventricle and aortic root injection were included in the study. Of 515 angiograms with visible coronaries, 42 patients (20 males, 22 females; mean age: 5.3±2.0 years) were found to have final diagnosis of coronary anomaly. Prevalence of coronary artery anomalies was 8.16% in this study. It was determined that 38 (90.4%) were anomalies of origination, 2 (4.8%) were anomalies of intrinsic coronary arterial anatomy, and 2 (4.8%) were anomalies of coronary termination. Most common coronary artery abnormality was anomalous origin of the right coronary artery from the left aortic sinus (16 patients; 38.1%), and the most common congenital heart disease was tetralogy of Fallot (18 patients; 42.9%). Recognizing variability of coronary artery anomalies is critical when considering surgical or interventional therapies in children with congenital heart disease.
- 1 January 2017
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 45 (6) , 5-532
Open AccessPrevalence and characteristics of coronary artery anomalies in children with congenital heart disease diagnosed with coronary angiography
Aim of the present study was to determine the prevalence of coronary artery anomalies in children with congenital heart disease. Data of 1138 consecutive patients who were referred for cardiac catheterization and angiography for assessment of coronary anomaly between January 2005 and December 2009 were retrospectively analyzed. Total of 515 patients whose coronary arteries could be examined through left ventricle and aortic root injection were included in the study. Of 515 angiograms with visible coronaries, 42 patients (20 males, 22 females; mean age: 5.3±2.0 years) were found to have final diagnosis of coronary anomaly. Prevalence of coronary artery anomalies was 8.16% in this study. It was determined that 38 (90.4%) were anomalies of origination, 2 (4.8%) were anomalies of intrinsic coronary arterial anatomy, and 2 (4.8%) were anomalies of coronary termination. Most common coronary artery abnormality was anomalous origin of the right coronary artery from the left aortic sinus (16 patients; 38.1%), and the most common congenital heart disease was tetralogy of Fallot (18 patients; 42.9%). Recognizing variability of coronary artery anomalies is critical when considering surgical or interventional therapies in children with congenital heart disease.
- 7 July 2016
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (11) , 2940-2945
Bacterial agents causing meningitis during 2013–2014 in Turkey: A multi-center hospital-based prospective surveillance study
This is an observational epidemiological study to describe causes of bacterial meningitis among persons between 1 month and 18 y of age who are hospitalized with suspected bacterial meningitis in 7 Turkish regions. covering 32% of the entire population of Turkey. We present here the results from 2013 and 2014. A clinical case with meningitis was defined according to followings: any sign of meningitis including fever, vomiting, headache, and meningeal irritation in children above one year of age and fever without any documented source, impaired consciousness, prostration and seizures in those < 1 y of age. Single tube multiplex PCR assay was performed for the simultaneous identification of bacterial agents. The specific gene targets were ctrA, bex, and ply for N. meningitidis, Hib, and S. pneumoniae, respectively. PCR positive samples were recorded as laboratory-confirmed acute bacterial meningitis. A total of 665 children were hospitalized for suspected acute meningitis. The annual incidences of acute laboratory-confirmed bacterial meningitis were 0.3 cases / 100,000 population in 2013 and 0.9 cases/100,000 in 2014. Of the 94 diagnosed cases of bacterial meningitis by PCR, 85 (90.4%) were meningococcal and 9 (9.6%) were pneumococcal. Hib was not detected in any of the patients. Among meningococcal meningitis, cases of serogroup Y, A, B and W-135 were 2.4% (n = 2), 3.5% (n = 3), 32.9% (n = 28), and 42.4% (n = 36). No serogroup C was detected among meningococcal cases. Successful vaccination policies for protection from bacterial meningitis are dependent on accurate determination of the etiology of bacterial meningitis. Additionally, the epidemiology of meningococcal disease is dynamic and close monitoring of serogroup distribution is comprehensively needed to assess the benefit of adding meningococcal vaccines to the routine immunization program.
- 7 July 2016
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (11) , 2940-2945
Bacterial agents causing meningitis during 2013–2014 in Turkey: A multi-center hospital-based prospective surveillance study
This is an observational epidemiological study to describe causes of bacterial meningitis among persons between 1 month and 18 y of age who are hospitalized with suspected bacterial meningitis in 7 Turkish regions. covering 32% of the entire population of Turkey. We present here the results from 2013 and 2014. A clinical case with meningitis was defined according to followings: any sign of meningitis including fever, vomiting, headache, and meningeal irritation in children above one year of age and fever without any documented source, impaired consciousness, prostration and seizures in those < 1 y of age. Single tube multiplex PCR assay was performed for the simultaneous identification of bacterial agents. The specific gene targets were ctrA, bex, and ply for N. meningitidis, Hib, and S. pneumoniae, respectively. PCR positive samples were recorded as laboratory-confirmed acute bacterial meningitis. A total of 665 children were hospitalized for suspected acute meningitis. The annual incidences of acute laboratory-confirmed bacterial meningitis were 0.3 cases / 100,000 population in 2013 and 0.9 cases/100,000 in 2014. Of the 94 diagnosed cases of bacterial meningitis by PCR, 85 (90.4%) were meningococcal and 9 (9.6%) were pneumococcal. Hib was not detected in any of the patients. Among meningococcal meningitis, cases of serogroup Y, A, B and W-135 were 2.4% (n = 2), 3.5% (n = 3), 32.9% (n = 28), and 42.4% (n = 36). No serogroup C was detected among meningococcal cases. Successful vaccination policies for protection from bacterial meningitis are dependent on accurate determination of the etiology of bacterial meningitis. Additionally, the epidemiology of meningococcal disease is dynamic and close monitoring of serogroup distribution is comprehensively needed to assess the benefit of adding meningococcal vaccines to the routine immunization program.